Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-08
1998-07-07
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514339, A61K 3144
Patent
active
057769559
ABSTRACT:
This invention relates to a method of treating a patient in need of relief from convulsions which comprises administering to such a patient a convulsion-alleviating amount of a compound of the formula ##STR1## wherein R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, m and n are as defined within.
REFERENCES:
patent: 4868190 (1989-09-01), Effland et al.
patent: 4880822 (1989-11-01), Effland et al.
patent: 4970218 (1990-11-01), Effland et al.
patent: 5032599 (1991-07-01), Effland et al.
patent: 5053511 (1991-10-01), Effland et al.
patent: 5179099 (1993-01-01), Effland et al.
patent: 5296488 (1994-03-01), Effland et al.
patent: 5356910 (1994-10-01), Kongsamut et al.
Tang, L. et al, Effects of besipirdine at the voltage-dependent sodium channel:, British Journal of Pharmacology (Nov., 1995) 116, pp. 2468-2472.
Huger Francis Parker
Kongsamut Sathapana
Smith Craig Paul
Tang Lei
Gupta Balaram
Hoechst Marion Roussel Inc.
Jordan Kimberly
Kurys Barbara E.
LandOfFree
Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206340